INDP Indaptus Therapeutics Inc
|
2,847,380.0
|
12,076,500.0
|
CNTX Context Therapeutics Inc
|
4,191,720.0
|
11,871,020.0
|
JAN Janone Inc
|
7,285,000.0
|
11,202,000.0
|
IKT Inhibikase Therapeutics Inc
|
3,528,730.0
|
10,977,920.0
|
MTEX Mannatech Inc
|
30,722,000.0
|
10,484,000.0
|
XBIO Xenetic Biosciences Inc
|
809,590.0
|
9,795,640.0
|
BMRA Biomerica Inc
|
2,534,000.0
|
7,808,000.0
|
PHIO Phio Pharmaceuticals Corp
|
1,634,000.0
|
7,730,000.0
|
AVTX Avalo Therapeutics Inc
|
13,689,000.0
|
7,304,000.0
|
PRFX PainReform Ltd
|
2,691,000.0
|
7,239,000.0
|
SNOA Sonoma Pharmaceuticals Inc
|
7,926,000.0
|
6,692,000.0
|
TCRT Alaunos Therapeutics Inc
|
1,956,000.0
|
6,307,000.0
|
KPRX Kiora Pharmaceuticals Inc
|
7,602,220.0
|
6,109,650.0
|
RVPH Reviva Pharmaceuticals Holdings, Inc.
|
17,981,670.0
|
5,718,720.0
|
NTRB Nutriband Inc
|
2,811,740.0
|
5,711,340.0
|
QNRX Quoin Pharmaceuticals Ltd
|
6,505,210.0
|
5,664,020.0
|
SLRX Salarius Pharmaceuticals Inc
|
1,299,240.0
|
5,287,280.0
|
PCSA Processa Pharmaceuticals Inc
|
797,480.0
|
4,989,160.0
|
JAGX Jaguar Health Inc
|
45,802,000.0
|
4,961,000.0
|
MTEM Molecular Templates Inc
|
31,171,000.0
|
4,212,000.0
|
RNAZ Transcode Therapeutics Inc
|
3,528,890.0
|
1,640,810.0
|
ATXI Avenue Therapeutics Inc
|
268,000.0
|
1,582,000.0
|
BPTH Bio Path Holdings Inc
|
2,779,000.0
|
441,000.0
|
VVOS Vivos Therapeutics Inc
|
10,319,000.0
|
411,000.0
|
PSTV Plus Therapeutics Inc
|
12,736,000.0
|
-1,348,000.0
|
ACHV Achieve Life Sciences Inc
|
20,819,000.0
|
-1,448,000.0
|
CSBR Champions Oncology Inc
|
28,845,000.0
|
-2,058,000.0
|
PYPD PolyPid Ltd
|
17,468,000.0
|
-2,096,000.0
|
QLGN Qualigen Therapeutics Inc
|
4,136,810.0
|
-2,103,560.0
|
UNCY Unicycive Therapeutics Inc
|
18,000,000.0
|
-3,809,000.0
|
ITRM Iterum Therapeutics PLC
|
32,662,000.0
|
-6,403,000.0
|
XERS Xeris Biopharma Holdings Inc
|
329,384,000.0
|
-6,782,000.0
|
CRBP Corbus Pharmaceuticals Holdings Inc
|
35,177,120.0
|
-6,904,720.0
|
FENC Fennec Pharmaceuticals Inc
|
38,486,000.0
|
-11,622,000.0
|
NRXP NRX Pharmaceuticals Inc
|
19,048,000.0
|
-11,733,000.0
|
NERV Minerva Neurosciences Inc
|
85,357,240.0
|
-28,457,490.0
|
RIGL Rigel Pharmaceuticals Inc
|
145,869,000.0
|
-28,644,000.0
|
AKBA Akebia Therapeutics Inc
|
272,287,000.0
|
-30,584,000.0
|
HRTX Heron Therapeutics Inc
|
256,479,000.0
|
-33,973,000.0
|
GALT Galectin Therapeutics Inc
|
88,441,000.0
|
-60,241,000.0
|
FHTX Foghorn Therapeutics Inc.
|
363,106,000.0
|
-77,190,000.0
|
OPTN OptiNose Inc
|
194,335,000.0
|
-86,606,000.0
|
AQST Aquestive Therapeutics Inc
|
163,905,000.0
|
-106,487,000.0
|
KPTI Karyopharm Therapeutics Inc
|
376,644,000.0
|
-136,206,000.0
|
FGEN FibroGen Inc
|
627,695,000.0
|
-204,166,000.0
|
IRWD Ironwood Pharmaceuticals Inc
|
817,368,000.0
|
-346,295,000.0
|
ESPR Esperion Therapeutics Inc
|
660,790,000.0
|
-454,994,000.0
|
BCRX BioCryst Pharmaceuticals Inc
|
972,488,000.0
|
-455,528,000.0
|
PTCT PTC Therapeutics Inc
|
2,714,253,000.0
|
-818,555,000.0
|
CAH 卡地納健康
|
50,022,000,000.0
|
-3,449,000,000.0
|